Effect of ozanimod (RPC1063) on action potential parameters in adult human Purkinje fibres

被引：0
|
作者：
Abi-Gerges, N. [1 ]
Miller, P. E. [1 ]
Ghetti, A. [1 ]
Scott, F. L. [2 ]
Meadows, K. R. Taylor [2 ]
Clemons, B. [2 ]
Frohna, P. [2 ]
Opiteck, G. J. [2 ]
机构：
[1] AnaBios Corp, San Diego, CA USA
[2] Receptos, San Diego, CA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P440
引用
收藏
页码：181 / 182
页数：2
相关论文
共 50 条
  • [1] Ozanimod (RPC1063) is potentially neuroprotective through direct CNS effects
    Meadows, K. R. Taylor
    Selkirk, J. V.
    Akhtar, M. W.
    Hutton, C.
    Opiteck, G. J.
    Scott, F. L.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 624 - 624
  • [2] Ozanimod (RPC1063) reduces the plasma biomarker neurofilament light chain in preclinical rodent models of multiple sclerosis
    Meadows, K. R. Taylor
    Scott, F. L.
    Villescaz, C.
    Clemons, B.
    Lopez, C.
    Sawa-Ballweber, S.
    Dines, K.
    Opiteck, G. J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 842 - 843
  • [3] Ozanimod(RPC1063)在少突胶质前体细胞分化中的作用和机制
    张莹
    孔祥熙
    侯琳
    王树坤
    袁增强
    中国生物工程杂志, 2020, 40 (06) : 10 - 19
  • [4] Ozanimod (RPC1063) Potentially Confers Neuroprotective Benefit through Modulation of S1P1R on Astrocytes
    Meadows, Kristen R. Taylor
    Akhtar, Mohd Waseem
    Villescaz, Christiane
    Clemons, Bryan
    Lopez, Carlos
    Sawa-Ballweber, Samantha
    Dines, Kevin
    Opiteck, Gregory J.
    Scott, Fiona L.
    Selkirk, Julie V.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 82 - 83
  • [5] Ozanimod (RPC1063) Preserves Central Nervous System (CNS) Tissue in Rodents by Reducing Neuronal Breaks in Vivo and Modulating Astrocyte Activity in Vitro
    Meadows, Kristen Taylor
    Akhtar, Mohd Waseem
    Brand, Morgan
    Villescaz, Christiane
    Clemons, Bryan
    Lopez, Carlos
    Sawa-Ballweber, Samantha
    Dines, Kevin
    Opiteck, Gregory
    Scott, Fiona
    Selkirk, Julie
    NEUROLOGY, 2018, 90
  • [6] Discovery of ozanimod (RPC1063): A S1P1R and S1P5R selective agonist for the treatment of autoimmune disease
    Tamiya, Junko
    Martinborough, Esther
    Yeager, Adam
    Huang, Liming
    Enugurthi, Brahmachary
    Moorjani, Manisha
    Boehm, Marcus
    Scott, Fiona
    Clemons, Bryan
    Brooks, Jennifer
    Powell, Rachel
    Dedman, Harry
    Desale, Hans
    Reinhart, Gregory
    Timony, Gregg
    Peach, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [7] Ozanimod (RPC1063) is potentially neuroprotective through direct activity on Th1 and Th17 T cell expansion and migration, monocyte migration and microglia expansion
    Guimond, D.
    Boyett, M.
    Lopez, C.
    Sawa-Ballweber, S.
    Villescaz, C.
    Dines, K.
    Opiteck, G. J.
    Scott, F. L.
    Meadows, K. R. Taylor
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 623 - 623
  • [8] Safety and tolerability of orally administered RPC1063, a novel S1P1 receptor agonist, in healthy adult volunteers
    Hartung, J.
    Peach, R.
    Boehm, M.
    Rosen, H.
    Smith, H.
    Pan, C.
    Brooks, J.
    Timony, G.
    Gujrathi, S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 186 - 186
  • [9] DURATION OF ACTION POTENTIAL AS A FUNCTION OF MEMBRANE POTENTIAL IN CARDIAC PURKINJE FIBRES
    CARMELIET, EE
    VANDERWA.JJ
    JOURNAL OF PHYSIOLOGY-LONDON, 1968, 194 (02): : P88 - +
  • [10] EFFECT OF MANGANESE IONS ON ACTION POTENTIAL AND IONIC CURRENT IN CARDIAC PURKINJE-FIBRES
    VITEK, M
    TRAUTWEIN, W
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1970, 319 (3-4): : R113 - +
12345